Tech Company Financing Transactions
GnuBio Funding Round
GnuBio, based in Cambridge, raised $10 million from private investors.
Transaction Overview
Company Name
Announced On
10/2/2012
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
1 Kendall Square Bldg 1400 14201
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Overview
GnuBIO is a genomics company developing next-generation sequencing technology for the molecular diagnostic and applied research markets. The GnuBIO system is based on emulsion and microfluidic technology developed at Harvard University.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Boyce
Chief Financial Officer
Susie Harborth
VP - Product Management
Sepehr Kiani
Browse more venture capital transactions:
Prev: 10/2/2012: Diffusion Pharmaceuticals venture capital transaction
Next: 10/2/2012: Bottlenose venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to record every notable VC transaction. All VC database entries reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs